Lupin reported a 1.1 percent fall in its fourth quarter net profit to Rs 547 crore as against Rs 553 crore in the corresponding quarter last fiscal. In an interview to CNBC-TV18, Abhishek Sharma, pharma analyst at IIFL, and Surajit Pal of Prabhudas Lilladher, analyse the results.
first published: May 13, 2015 03:58 pm
A collection of the most-viewed Moneycontrol videos.
Meesho's Rs 5,421 Cr IPO Kicks Off| Post-IPO Playbook, Profitability Path & More| IPO Watch Live
Can Nifty Hold Above 26,000 Amid Currency Jitters? Meesho IPO Opens | Opening Bell Live
Nifty Struggles Below 26,100 On Weekly F&O Expiry As Rupee Hits New Low| Closing Bell Live
Will Rupee Slide & Expiry Day Caution Keep Nifty Bulls On The Back Foot? | Opening Bell Live
